Jan 29, 2020 17:20 JST

Source: NEC Corporation

NEC Announces Executive Personnel Changes

TOKYO, Jan 29, 2020 - (JCN Newswire) - NEC Corporation (TSE: 6701) today announced the following executive personnel changes. The changes were approved at a meeting of the Board of Directors on January 29, 2020 and will become effective as of April 1, 2020.

About the Executive Organization

NEC places the highest priority on achieving the Mid-term Management Plan 2020, which is the final year in FY2020, and will build a system to more strongly promote R&D and productivity improvement process reforms in order to grow over the medium to long term, without making significant changes to the company structure.

(1) Strengthening Core Competitiveness with R&D - Acceleration of Commercialization
NEC will establish a new Research & Development Unit that integrates the central research labs and intellectual property/technology strategy division in order to accelerate company-wide deployment and sharing of infrastructure technology owned by the business units, as well as create business models that maximize technological value through co-creation on an industry-by-industry basis, in addition to maintaining and expanding NEC's core technologies.

(2) Strengthening Process Reform Functions.
Appointing a full-time executive officer to further accelerate business process reform of staff, led by NEC Management Partner Co., Ltd. as part of profit structure reform.

Formore information, visit https://www.nec.com/en/press/202001/global_20200129_02.html.

Source: NEC Corporation
Sectors: Cloud & Enterprise

Copyright ©2024 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.

Related Press Release


NEC Strengthens Commitment to Space Industry with Investment in Seraphim Space Venture Fund II
April 22 2024 14:09 JST
 
DOCOMO, NTT, NEC and Fujitsu Develop Top-level Sub-terahertz 6G Device Capable of Ultra-high-speed 100 Gbps Transmission
April 11 2024 14:10 JST
 
Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024
April 10 2024 12:36 JST
 
NEC white paper proposes comprehensive process workflow for the application of AI-driven personalized cancer vaccines
April 08 2024 12:45 JST
 
NEC develops marketing strategy planning & effectiveness simulation technology using generative AI
March 25 2024 09:08 JST
 
NEC and NTT successfully conduct first-of-its-kind long-distance transmission experiment over 7,000km using 12-core optical fiber
March 22 2024 07:38 JST
 
NEC and Tokyo Medical and Dental University use AI to assist self-care for chronic lower back pain
March 21 2024 09:02 JST
 
NEC and Skyloom to Pioneer 100 Gbps Space Optical Communications, Transforming Global Internet Connectivity
March 20 2024 14:30 JST
 
NEC named to list of Top 100 Global Innovators by Clarivate for 13th consecutive year
March 07 2024 10:24 JST
 
Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050
March 05 2024 08:05 JST
 
More Press release >>

Latest Press Release


More Latest Release >>